Landauer Inc. (LDR) Lowered to Hold at Zacks Investment Research
Landauer Inc. (NYSE:LDR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday.
According to Zacks, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries. “
A number of other equities analysts also recently weighed in on the stock. Sidoti downgraded shares of Landauer from a “buy” rating to a “neutral” rating and set a $52.00 target price for the company. in a research note on Tuesday, August 16th. Hilliard Lyons downgraded shares of Landauer from a “neutral” rating to an “underperform” rating in a research note on Friday, July 1st.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/11/landauer-inc-ldr-lowered-to-hold-at-zacks-investment-research.html
Shares of Landauer (NYSE:LDR) opened at 45.37 on Tuesday. The company has a 50-day moving average of $45.59 and a 200 day moving average of $40.59. The firm has a market capitalization of $435.69 million, a P/E ratio of 24.52 and a beta of 1.08. Landauer has a 52 week low of $26.99 and a 52 week high of $49.74.
Landauer (NYSE:LDR) last announced its earnings results on Monday, August 8th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.19. Landauer had a net margin of 11.63% and a return on equity of 102.93%. The business earned $37.90 million during the quarter, compared to the consensus estimate of $35.24 million. Equities research analysts anticipate that Landauer will post $1.76 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, October 5th. Shareholders of record on Friday, September 16th were paid a $0.275 dividend. This represents a $1.10 annualized dividend and a yield of 2.42%. The ex-dividend date was Wednesday, September 14th. Landauer’s dividend payout ratio (DPR) is currently 59.14%.
A number of large investors have recently bought and sold shares of the stock. Chartwell Investment Partners LLC bought a new stake in Landauer during the second quarter valued at $20,161,000. Riverhead Capital Management LLC increased its stake in Landauer by 94,098.7% in the second quarter. Riverhead Capital Management LLC now owns 141,298 shares of the company’s stock valued at $11,876,000 after buying an additional 141,148 shares during the period. Royce & Associates LP increased its stake in Landauer by 6.2% in the first quarter. Royce & Associates LP now owns 1,122,543 shares of the company’s stock valued at $37,122,000 after buying an additional 65,814 shares during the period. Lafitte Capital Management LP bought a new stake in Landauer during the first quarter valued at $1,984,000. Finally, Vanguard Group Inc. increased its stake in Landauer by 6.0% in the second quarter. Vanguard Group Inc. now owns 771,711 shares of the company’s stock valued at $31,764,000 after buying an additional 43,370 shares during the period. 86.34% of the stock is owned by hedge funds and other institutional investors.
Landauer, Inc (Landauer) is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a domestic provider of outsourced medical physics services and a provider of radiology related medical products. It operates in three business segments: Radiation Measurement, Medical Physics and Medical Products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.